DAMORA THERAPEUTICS, INC. (DMRA) Net income 2019–2025
DAMORA THERAPEUTICS, INC. (DMRA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$209.8MFY2025 · since FY2019: -$36.5M → -$209.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$209.8M | -878.8% |
| FY2024 | -$21.4M | +44.1% |
| FY2023 | -$38.3M | +37.8% |
| FY2022 | -$61.6M | -19.1% |
| FY2021 | -$51.8M | -48.6% |
| FY2020 | -$34.8M | +4.6% |
| FY2019 | -$36.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DMRA financial trends
DMRA RevenueDMRA Net marginDMRA Gross profitDMRA Gross marginDMRA Operating incomeDMRA Operating marginDMRA Operating cash flowDMRA Free cash flowDMRA Capital expendituresDMRA Return on equityDMRA Stock buybacksDMRA Dividends paidDMRA Total assetsDMRA Total liabilitiesDMRA Shareholders’ equityDMRA overview →